티앤알바이오팹

246710· KOSDAQ· Health Care· Health Care Equipment & Services

₩2,275+0.22%

2026-09-18

Financials

Valuation Metrics

티앤알바이오팹's Market Cap is ₩1084B. At end of 2025 it was ₩1864B. Ranked #1233 of 2,421 in KR market (top 51%), #668 of 1,640 on KOSDAQ (top 41%), #43 of 96 in Health Care Equipment & Services (top 45%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	108.44B KRW	KR#1,233/2,421 Sec#43/96
Revenue	32.73B KRW	KR#2,000/2,421 Sec#61/96
Net Income	-27.71B KRW	KR—/2,421 Sec—/96
Total Assets	92.75B KRW	KR#1,838/2,421 Sec#55/96
Net Assets	21.20B KRW	KR#2,275/2,421 Sec#85/96
Employees	97	KR#1,660/2,421 Sec#61/96
Value
P/B	5.11x	KR#2,248/2,421 Sec#90/96
P/S	3.31x	KR#2,021/2,421 Sec#67/96
Profitability
ROE	-130.69%	KR#2,366/2,421 Sec#93/96
ROA	-29.88%	KR#2,320/2,421 Sec#87/96
Op. Margin	-16.54%	KR#2,086/2,421 Sec#69/96
Revenue Growth	120.91%	KR#69/2,421 Sec#6/96
Financial Health
Debt Ratio	337.44%	KR#2,278/2,421 Sec#94/96
Total Debt	29.71B KRW	KR#1,237/2,421 Sec#31/96
Cash	6.03B KRW	KR#1,935/2,421 Sec#65/96
Current Ratio	0.33x	KR#2,202/2,421 Sec#93/96
Performance
1Y Return	18.49%	KR#460/2,421 Sec#11/96
1M Return	-5.41%	KR#1,828/2,421 Sec#57/96
From 52W High	-53.81%	KR#1,584/2,421 Sec#48/96
1Y MDD	-60.15%	KR#1,485/2,421 Sec#51/96
Trading
Volume	75,482 shares	KR#929/2,421 Sec#33/96
Trading Value	173.2M KRW	KR#1,328/2,421 Sec#54/96
Foreign Own.	2.63%	KR#1,412/2,421 Sec#51/96
Per Share
EPS	-581 KRW	KR—/2,421 Sec—/96
BPS	445 KRW	KR#2,389/2,421 Sec#95/96

Company Info

CEO 윤원수

Employees 97

Founded 2013

HQ 경기도 시흥시, KR

Website www.tnrbiofab.com

동사는 2013년 설립, 2018년 코스닥 상장, 2025년 종속회사 블리스팩투자목적회사와 블리스팩 합병 완료함. 조직공학 및 재생의학 기술 기반 3D 바이오프린팅 시스템, 바이오잉크, 생분해성 인공지지체 제조하며 재생의학, 바이오써지컬솔루션, 화장품 사업 영위함. 3D 오가노이드 및 세포치료제 연구개발 중이며 중단기 수익 확보 위해 재생의학 기술 적용한 바이오써지컬 솔루션 사업 전개, 화장품 사업 확장하고 있음. 티앤알바이오팹는 2013년에 설립되었으며 경기도 시흥시에 본사를 두고 있습니다.